Skip to main content
Clinical Trials/NCT03990727
NCT03990727
Recruiting
Not Applicable

Phenotype Correlates Genotype of Inherited Retina Dystrophies

MejoraVisionMD1 site in 1 country17,000 target enrollmentAugust 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Retinitis Pigmentosa
Sponsor
MejoraVisionMD
Enrollment
17000
Locations
1
Primary Endpoint
Gene-molecular variation to correlate with phenotype based on autofluorescence, retina analysis,
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

Patients with retina dystrophies (retinitis pigmentosa, cone>rods dystrophies, Usher and syndromic) will be correlated with genotype and validate inheritance mode by segregation analysis.

Detailed Description

Patients with retina dystrophies (retinitis pigmentosa, cone\>rods dystrophies, Usher and syndromic, etc.) will be correlated with genotype and validate inheritance mode by segregation analysis. Ocular exam of proband, parents and two unaffected siblings is needed, retina analysis, autofluorescence and ocular coherence tomography (OCT) are needed as well as family map. Blood samples 10ml max blood extraction will be sent and genotype will be analyzed.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
September 30, 2025
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
MejoraVisionMD
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of inherited retina dystrophy or retinitis pigmentosa
  • Must be able to perform all study tests.
  • Must be able to visit every year.

Exclusion Criteria

  • Not willing to visit every year.

Outcomes

Primary Outcomes

Gene-molecular variation to correlate with phenotype based on autofluorescence, retina analysis,

Time Frame: 8 years

Molecular variation correlates with specific phenotype based on autofluorescence, retina analysis, macular coherence tomography.

Secondary Outcomes

  • Preliminary Natural History(5 years)

Study Sites (1)

Loading locations...

Similar Trials